References
- Ekström K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum. 2003;48:963–70.
- Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54:692–701.
- Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum. 2004;50:1740–51.
- Harris NL, Swerdlow SH. Immunodeficiency associated lym-phoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 255–71.
- Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma devel-opment: 26 cases reported to the Food and Drug Administration. Arthritis Rheum. 2002;46: 3151–8.
- Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of obser-vation. Arthritis Rheum. 2007;56:1433–9.
- Baecklund E, Sundström C, Ekbom A, Catrina AT, Biberfeld P, Feltelius N, et al. Lymphoma subtypes in patients with rheuma-toid arthritis. Increased proportion of diffuse large B cell lymphoma. Arthritis Rheum. 2003;48:1543–50.
- Kamel OW, van de Rijn M, Weiss LM, Del Zoppo JD, Hench PK, Robbins BA, et al. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med. 1993;328:1317–21.
- Hoshida Y, Yamamoto S, Wada N, Xu J-X, Sasaki T, Aozasa K. Infliximab-associated lymphoproliferative disorders. Int J Hematol. 2005;81:356-7 (letter).
- Oyama T, Ichimura K, Suzuki R, Suzumiya J, Ohshima K, Yatabe Y, et al. Senile EBV+ B-cell lymphoproliferative disor-ders: a clinicopathologic study of 22 patients. Am J Surg Pathol. 2003;27:16–26.